2019
DOI: 10.1111/pace.13789
|View full text |Cite
|
Sign up to set email alerts
|

Factors predicting persistence of AV nodal block in post‐TAVR patients following permanent pacemaker implantation

Abstract: Introduction A common complication of transcatheter aortic valve repair (TAVR) is development of conduction defects requiring pacemaker (PPM) implantation. These defects are not universally permanent. Objective To determine the incidence and predictors of persistent device dependency in patients with PPM implantation following TAVR with a self‐expanding prosthesis. Methods Records of patients who underwent post‐TAVR PPM implantation were reviewed. Patients with persistent complete AV block (AVBIII) one month p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 22 publications
(83 reference statements)
3
10
0
Order By: Relevance
“…The incidence rate of PPM implantation within 30 days after TAVR in our institution (8.4%) is comparable to that reported by the PARTNER 1, 2, and 3 trials that used balloon‐expandable valves (6.6%‐8.8%) 3,5,7 . It is lower however than a lot of recently reported single institutional experiences that used both self‐expanding and balloon expandable valves (incidence rates between 11% and 28%) 10,11,13,14,16,17 . These interinstitutional differences may be partly explained by our higher use of balloon‐expandable valves (77%) which are generally associated with a lower risk of PPM implantation due to their higher level of implantation, 18 as well as our use of newer generation self‐expanding Evolut valves rather than first generation CoreValves which have a lower risk of PPM implantation 19 .…”
Section: Discussionsupporting
confidence: 72%
See 4 more Smart Citations
“…The incidence rate of PPM implantation within 30 days after TAVR in our institution (8.4%) is comparable to that reported by the PARTNER 1, 2, and 3 trials that used balloon‐expandable valves (6.6%‐8.8%) 3,5,7 . It is lower however than a lot of recently reported single institutional experiences that used both self‐expanding and balloon expandable valves (incidence rates between 11% and 28%) 10,11,13,14,16,17 . These interinstitutional differences may be partly explained by our higher use of balloon‐expandable valves (77%) which are generally associated with a lower risk of PPM implantation due to their higher level of implantation, 18 as well as our use of newer generation self‐expanding Evolut valves rather than first generation CoreValves which have a lower risk of PPM implantation 19 .…”
Section: Discussionsupporting
confidence: 72%
“…3,5,7 It is lower however than a lot of recently reported single institutional experiences that used both self-expanding and balloon expandable valves (incidence rates between 11% and 28%). 10,11,13,14,16,17 These interinstitutional differences may be partly explained by our higher use of balloon-expandable valves (77%) which are generally associated with a lower risk of PPM implantation due to their higher level of implantation, 18 as well as our use of newer generation self-expanding Evolut valves rather than first generation Cor-eValves which have a lower risk of PPM implantation. 19 However despite these factors, there is still a high variability between institutional experiences with rates of PPM implantation after TAVR 19 which in the atrioventricular node and interventricular conduction system.…”
Section: Discussionmentioning
confidence: 97%
See 3 more Smart Citations